Documents - 2020

Displaying 1 - 8 of 8 results
 
Collapse Filters
 
Expand Filters         +
March 6, 2020

Fentanyl Flow to the United States

The flow of fentanyl into the United States in 2019 is more diverse compared to the start of the fentanyl crisis in 2014, with new source countries and new transit countries emerging as significant trafficking nodes. This is exacerbating the already multi-faceted fentanyl crisis by introducing additional source countries into the global supply chain of fentanyl, fentanyl-related substances, and fentanyl precursors. Further, this complicates law enforcement operations and policy efforts to stem the flow of fentanyl into the United States. While Mexico and China are the primary source countries for fentanyl and fentanyl-related substances trafficked directly into the United States, India is emerging as a source for finished fentanyl powder and fentanyl precursor chemicals.

March 3, 2020

Statement of Thomas Prevoznik, Deputy Assistant Administrator, Diversion Control Division: Combatting an Epidemic: Legislation to Help Patients With Substance Use Disorders

Statement of Thomas Prevoznik Deputy Assistant Administrator Diversion Control Division Drug Enforcement Administration U.S. Department of Justice Before the Subcommittee on Health House Committee on Energy and Commerce U.S. House of Representatives at a hearing entitled “Combatting an epidemic: legislation to help patients with substance use disorders” presented March 3, 2020

February 26, 2020

NFLIS Findings for Synthetic Cannabinoid Substance in New Orleans

The DEA New Orleans Division conducted a five-year review of the data on synthetic substances reported in the National Forensic Laboratory Information System for their area of responsibility. The findings revealed that Louisiana submitted the majority of reports for synthetic cannabinoid substance and synthetic cathinones substance for 2013 to 2017. Synthetic cannabinoid substance and synthetic cathinones are classified as new psychoactive substances (NPS).

February 20, 2020

Acting Administrator Uttam Dhillon on Operation Crystal Shield

DEA Acting Administrator Uttam Dhillon announces Operation Crystal Shield in response to a dramatic increase in methamphetamine trafficking through eight major cities in the U.S.  The press conference took place at the DEA Field Division Headquarters in Atlanta, Georgia on February 20, 2020.

January 30, 2020

2019 National Drug Threat Assessment

The 2019 National Drug Threat Assessment (NDTA) is a comprehensive strategic assessment of the threat posed to the United States by domestic and international drug trafficking and the abuse of both licit and illicit drugs. The report combines federal, state, local, and tribal law enforcement reporting; public health data; open source reporting; and intelligence from other government agencies to determine which substances and criminal organizations represent the greatest threat to the United States.

January 21, 2020

DEA 360 Strategy Reach and Impact Report: NEWARK

This report describes the methods and results of an assessment of the reach and impact of community outreach activities of the DEA 360 Strategy in Newark. Results are based on a summary of metrics compiled from each program facilitator, as well as from interviews with community partners from across the region.

January 1, 2020

Prevention with a purpose

A strategic planning guide for preventing drug misuse among college students.

DEA US Badge
United States Drug Enforcement Administration DEA.gov is an official site of the U.S. Department of Justice